Skip to main content
. 2020 Feb 7;11:51. doi: 10.1186/s13287-020-1572-7

Fig. 3.

Fig. 3

Monitoring of anticoagulation by measuring activated clotting time (ACT) levels during and after intraportal infusion of HepaStem in patients (n = 11). ACT levels (targeted values 200–350 s; dotted horizontal lines) are represented for each patient during cell infusions (1–10)